SU5416 in Treating Patients With Metastatic Melanoma That Has Been Previously Treated
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
SU5416 may stop the growth of malignant melanoma by stopping blood flow to the tumor. Phase
II trial to study the effectiveness of SU5416 in treating patients who have metastatic
melanoma that has been previously treated